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Background: The amino-acid sequences of retroviral
envelope proteins contain a '4-3 hydrophobic repeat',
with hydrophobic amino acids spaced every four and then
every three residues, characteristic of sequences that form
coiled coils. The 4-3 hydrophobic repeat is located in the
transmembrane subunit (TM) of the retroviral envelope
protein, adjacent to the fusion peptide, a region that
inserts into the host bilayer during the membrane-fusion
process. A 4-3 hydrophobic repeat region in an analogous
position of the influenza hemagglutinin protein is
recruited to extend a three-stranded coiled coil during the
conformational change to the fusion-competent state. To
determine the conformation of the retroviral TM subunit
and the role of the 4-3 hydrophobic repeat, we con-
structed soluble peptide models of the envelope protein of
Moloney murine leukemia virus (MMLV).
Results: The region of the MMLV TM protein external
to the lipid envelope (the ectodomain) contains a stably
folded, trimeric, protease-resistant core. As predicted, an
(x-helical segment spans the 4-3 repeat. A cysteine-rich
region carboxy-terminal to the 4-3 repeat confers a
dramatic increase in stability and displays a unique
disulfide bonding pattern.
Conclusions: Our results demonstrate that the MMLV
TM subunit can fold into a stable and distinct species in the
absence of the receptor-binding 'surface' co-subunit (SU)
of the envelope complex. As the SU subunit is readily shed
from the surface of the virus, we conclude that the TM
subunit structure forms the core of the MMLV membrane-
fusion machinery, and that this structure, like the fusion-
active conformation of influenza hemagglutinin, contains a
three-stranded coiled coil adjacent to the fusion peptide.
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Background
The envelope (Env) proteins of retroviruses bind to cell-
surface receptors and promote fusion with the host cell
membrane [1]. The mechanism of retrovirus-mediated
membrane fusion has remained elusive, because of the
lack of detailed structural information about Env pro-
teins. Structural studies have been hindered by the low
virus titer in the natural systems studied, and by the large
size of the envelope complexes. Furthermore, the associ-
ation between the two Env subunits, termed the trans-
membrane (TM) and surface (SU) subunits, is labile, and
the protein complexes are membrane-bound.
By contrast, the hemagglutinin (HA) protein of the
orthomyxovirus influenza has been characterized by X-
ray crystallography in both the native [2] and the low-pH
activated forms [3]. These high-resolution HA structures,
together with other studies, have led to a model for HA-
mediated membrane fusion in which dissociation of the
receptor-binding domains from one another [4,5]
accompanies extension of a coiled coil to bring the
fusion peptides into a position that enables them to
interact with the target cell membrane [6]. The fusion-
active subunit would then bridge the viral and cellular
membranes to form a critical intermediate in the
membrane-fusion process.
Although the orthomyxovirus and retrovirus families
have no obvious evolutionary relationship, features of
influenza HA are similar to those of retroviral Env
proteins. First, both HA and Env are composed of two
fragments cleaved from a common precursor; in the case
of HA, these fragments are referred to as HA 1 and HA 2.
Like HA1, the retroviral SU glycoprotein binds to the
host-cell receptor [1]. The retroviral TM subunit con-
tains a hydrophobic sequence at its amino terminus anal-
ogous to the fusion peptide of the influenza HA 2 subunit
[7], which inserts into the target membrane [8,9]. The
retroviral TM subunit, like HA 2, contains a 4-3 hydro-
phobic repeat that is predicted to form a coiled coil
[10,11]. Finally, the shedding of the SU subunit of retro-
viruses such as HIV [12] and murine leukemia virus [13]
might parallel the displacement of influenza HA1 during
the conformational change to the fusogenic state.
The central features of the influenza fusogenic state were
preserved in the crystallized fragment of low-pH-
converted HA, despite the absence of the fusion peptide,
the transmembrane helix and most of the receptor-
binding domain [3]. Furthermore, the 'spring' to the
fusion-competent conformation was modeled using pep-
tides corresponding to only the coiled-coil regions of HA
[6]. We consequently undertook a protein dissection
study of a retrovirus Env protein in order to characterize
the structure of the retroviral membrane-fusion apparatus.
Moloney murine leukemia virus (MMLV) was chosen for
study because its TM subunit is small (15 kDa) and lacks
glycosylation sites. Moreover, the disulfide bond between
the MMLV SU and TM subunits can be eliminated by an
apparent disulfide rearrangement [13]. The requirement
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Fig. 1. Primary structure of the TM protein of MMLV. A linear map of the protein is shown, with the sequence (single-letter amino-acid
code) of Mo-92 specified. Regions modeled by the three peptides, named for the number of residues they contain, are indicated above
the sequence. Core residues of the 4-3 hydrophobic repeat are boxed in blue. The three cysteine thiols are numbered 1-3. The trypsin
cleavage site is marked by a pink arrow and the two chymotrypsin sites by purple arrows. A description of the immunosuppressive
region is found in the Discussion.
for disruption of a covalent bond during shedding of the
SU subunit implies a specific mechanism for the disposal
of SU. Therefore, the structure of the isolated TM sub-
unit of MMLV may be important in the membrane-
fusion mechanism of this retrovirus.
Peptides were designed to determine whether the
MMLV TM protein could fold independently of the SU
subunit. To avoid the difficulty of working with insolu-
ble peptides, we studied the hydrophilic segment of
the transmembrane protein by removing the fusion pep-
tide and the transmembrane region from our model
constructs.
Mo-92 is within two residues of the start of the protease-
resistant, and presumably well-folded, region.
Circular dichroism (CD) spectroscopy (Fig. 3) indicated
that our peptide model for the TM protein has a helix
content of approximately 59 % (Table 1). The Mo-92
Results
A peptide model of the TM subunit folds into a stable
structure
The primary structure of the MMLV TM protein is
shown in Figure 1. We produced a peptide, Mo-92, that
extends from Asp45 in the TM sequence to the begin-
ning of the transmembrane region. Asp45 was chosen
because it is at an f position near the beginning of the
4-3 hydrophobic repeat region, placing the positively
charged amino terminus away from the hydrophobic core
(Fig. 2), and was predicted by the Paircoil algorithm [14]
to be near the start of the coiled coil. To verify this
choice, a peptide was constructed starting at Met31 and
including the following additional sequence from the TM
protein: MATQQFQQLQAAVQ (single-letter amino-
acid code). When this peptide was subjected to proteoly-
sis with thermolysin, the amino terminus was trimmed to
Val43. Although thermolysin readily cleaves before
leucine residues, prolonged incubation did not result in
cleavage before Leu47. Therefore, the amino terminus of
Fig. 2. Helical wheel representation of Mo-36. The sequences of
coiled-coil proteins consist of 4-3 hydrophobic repeats, where
positions of the heptad are labeled with the letters a-g. The view
is down the helical axis starting at the amino terminus (position f)
of the peptide, which corresponds to residue Asp45 of the trans-
membrane protein. Core positions of the 4-3 hydrophobic repeat
(a and d) are highlighted in blue, and other positions are shown
in yellow.
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Fig. 3. CD spectra of peptide fragments of the TM protein. Each
fragment displays a characteristic helical spectrum at 2 C, with
double minima at 222 nm and 208 nm.
structure is remarkably stable, with a temperature mid-
point for thermal unfolding (Tm) of 86 C under physio-
logical conditions. Peptides truncated at the carboxyl
terminus, denoted Mo-55 and Mo-36 (Fig. 1), were
constructed to locate the secondary structure within Mo-
92. Mo-36 spans the 4-3 hydrophobic repeat region, and
the CD spectrum indicates that approximately 28
residues of this peptide are in a helical conformation; we
conclude that the 4-3 repeat region is helical. Because
the Mo-55 peptide contains no additional helical
residues, as judged by CD analysis, but is substantially
more stable than Mo-36 (Tm values of 80 C and 30 C,
respectively), we conclude that the immunosuppressive
and cysteine-rich regions, although folded, are in a non-
helical conformation.
Mo-92 has a higher helix content than Mo-55,
indicating that additional helical segment(s) are present
carboxy- terminal to the cysteine-rich region. However,
these segments do not confer a substantial increase in sta-
bility. A thermal melting study of Mo-92, in which the
CD signal was monitored at 222 nm, revealed a folded
Fig. 4. An estimate (see Materials and methods) of the number of
helical residues in each fragment plotted as a function of tempera-
ture. Mo-36 and Mo-55 lose most of their helicity during the coop-
erative unfolding transitions. On the other hand, approximately 20
helical residues - almost 40 % of the total helix content - unfold
in Mo-92 before the cooperative transition occurs.
baseline with a slope greater than that produced by
Mo-55. When the estimated number of helical residues
in each peptide is plotted against temperature (Fig. 4), it
appears that additional helical region(s) within Mo-92
melt non-cooperatively and independently, prior to the
transition for the amino-terminal helical region.
The TM protein forms a trimeric structure
The oligomerization state of the transmembrane protein
model peptide, Mo-92, was determined by analytical
ultracentrifugation. The data were consistent with a
trimer model over a nine-fold concentration range
(Fig. 5a). However, a systematic trend is observed in the
residuals between the data and the linear fit, becoming
more severe with increasing concentration. This behavior
is diagnostic of a tendency toward aggregation.
To pare away regions contributing to non-specific
aggregation, Mo-92 was subjected to proteolysis, and the
products were analyzed by mass spectrometry. Digestion
with trypsin (Fig. 1; pink arrow) or chymotrypsin (Fig. 1;
blue arrows) removed carboxy-terminal sequences but
left the amino terminus intact, yielding fragments similar
to Mo-55. Mo-55 thus corresponds to a protease-
resistant subdomain within the TM subunit. When
Mo-55 was subjected to analytical ultracentrifugation,
the resulting data fitted closely to a trimer model, and no
systematic residuals were observed (Fig. 5b).
TM protein contains a specific disulfide bond and a free thiol
The protease-resistant subdomain of the MMLV TM
protein contains three cysteine residues, the presence and
spacing of which are preserved in C- and D-type
retroviruses [15,16]. The formation of disulfide bonds
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Fig. 5. Equilibrium sedimentation of TM
protein model peptides. Representative
data are plotted as In(absorbance)
against the square of the radius from the
axis of rotation. The slope is propor-
tional to molecular mass (see Materials
and methods). Dashed lines with in-
creasing slopes indicate calculated val-
ues for monomeric (1), dimeric (2),
trimeric (3) and tetrameric (4) peptides.
(a) Data for Mo-92 are consistent with a
trimeric model, but with systematic resi-
duals, indicating a tendency to aggre-
gate. (b) Data for Mo-55 fit closely to a
trimeric model, but leave no systematic
residuals.
between these residues is therefore likely to be struc-
turally and/or functionally significant. Mapping of disul-
fide bonds in Mo-92 was challenging, because there are
adjacent cysteine residues that cannot be separated by
proteolysis. Instead, oxidized Mo-92 was incubated with
2-nitro-5-thiocyanobenzoic acid (NTCB), which cleaves
proteins at free cysteine residues [17].
NTCB-induced cleavage of Mo-92 yielded fragments
with molecular masses of 5 597 Da and 5 081 Da,
corresponding to the amino- and carboxy-terminal prod-
ucts, respectively, of cleavage at the third cysteine (C3) in
the TM sequence (Fig. 1). Control experiments using
reduced mutant proteins, in which specific cysteine
residues were replaced with alanine residues (used in the
disulfide-permutation experiments described below),
demonstrated that fragments resulting from cleavage at
either of the adjacent cysteine residues could be obtained
and readily distinguished from one another by mass
spectrometry. Thus, the NTCB cleavage results indicate
that only C3 in oxidized Mo-92 is reactive with NTCB,
and that C1 and C2 are likely to be protected by an
intramolecular disulfide bond. Cleavage of oxidized
Mo-55 produced a 5 600 Da amino-terminal fragment,
demonstrating that the protease-resistant core is sufficient
to specify the unique disulfide-bonding pattern that
leaves only C3 reactive with NTCB.
denoted Mo-92.3, was most stable, with a Tm of 86 C.
In contrast, the other two mutants (Mo-92.1 and
Mo-92.2) are substantially destabilized, with T,,, values of
76 C and 70 °C, respectively. The permutation experi-
ment, repeated using cysteine-to-alanine mutants of
Mo-55, gave qualitatively similar results (Table 2). Inter-
estingly, for both Mo-92 and Mo-55 backgrounds, the
folded baselines of the three disulfide variants were iden-
tical, indicating that alternate disulfide pairings accom-
modate the helical region completely, albeit with
impaired stability. These disulfide permutation experi-
ments are consistent with the NTCB cleavage data and
confirm that the most stable form of the isolated TM
protein contains a disulfide bond between C1 and C2.
Discussion
The structure of the retroviral TM protein is central to
viral entry into host cells for several reasons. Firstly, this
protein contains the fusion-peptide region. In addition,
To verify that C3 remains free as a result of the prefer-
ential formation of the C1-C2 disulfide bond, we
performed a disulfide permutation experiment. Three
mutant versions of Mo-92 were constructed by replacing
each cysteine individually with alanine. These mutant
peptides were oxidized in the presence of 6 M guanidine
hydrochloride (GuHCI) to remove structural barriers to
formation of non-native disulfide bonds. After refolding
by removal of GuHCl, the stability of each oxidized
peptide was assayed by thermal denaturation (Table 2).
The mutant with a disulfide bond between C1 and C2,
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the most highly conserved regions of the retroviral Env
proteins are present within the TM subunit. Carboxy-ter-
minal to the 4-3 hydrophobic repeat in C- and D-type
retroviruses the TM subunit invariably contains an 'im-
munosuppressive sequence' [15]. Peptides with the con-
sensus sequence for this region have been shown to
inhibit lymphocyte proliferation [18] and the production
of interferon y [19]. Adjacent to the immunosuppressive
region are the conserved cysteine residues, at least one of
which must be involved in the initial covalent association
with the MMLV SU subunit [20]. Furthermore, mutage-
nesis studies have shown that infectivity of MMLV is par-
ticularly sensitive to amino-acid substitutions [21] and
insertions [22] in the TM subunit. Finally, a construct
expressing the MMLV TM subunit alone partially com-
plements a non-fusogenic Env mutant anchored to the
viral membrane by a glycosylphosphatidylinositol linkage
[23]. These observations strongly suggest that efforts to
elucidate the mechanism of retrovirus-mediated mem-
brane fusion should target the TM subunit.
Conflicting reports have emerged regarding the oligo-
merization order of retroviral envelope proteins, such as
murine and feline leukemia viruses [24,25] and HIV
[26-28]. Peptide studies of the HIV TM protein located
a helical region in an analogous position to the MMLV
4-3 repeats, but the oligomerization state of these pep-
tides was ambiguous [29]. Our results show that the
region of the MMLV TM protein adjacent to the fusion
peptide forms a folded, helical and trimeric structure,
most likely as a three-stranded a-helical coiled coil.
The immunosuppressive region and the cysteine residues,
is also folded in our peptide model of the isolated
protein, as shown by the following observations: first,
these regions are present in the protease-resistant core;
second, the thermal stability of Mo-55 is considerably
greater than that of Mo-36; and third, only one of the
three potential intramolecular disulfide bonds is found.
The observation that a substantial portion of the TM
protein is stably folded in the absence of the SU subunit
supports our hypothesis that this conformation of the
TM protein corresponds to a functional state of the
retrovirus envelope.
The TM protein can be isolated on the surface of the
virus by a disulfide rearrangement that results in loss of
the SU subunit [13]. If shedding of the SU subunit
proves to be a required step in membrane fusion by retro-
viruses, then studying the connectivity of the disulfide
bonds in MMLV will provide a novel means of monitor-
ing the progress of a virus envelope protein through the
receptor-binding and membrane-fusion events. A disul-
fide-bonding pattern for the SU subunit released from a
murine leukemia virus has been proposed [30]. Our
studies show a preference for disulfide-bond formation
between the first and second cysteine residues in the
isolated TM subunit, leaving the third cysteine with a
free thiol. Identification of the disulfide-bonding pattern
in the SU-TM protein complex will reveal the nature
Fig. 6. Proposed model for the core of the fusion-active
conformation of the MMLV TM protein. Purple cylinders repre-
sent the three-stranded coiled coil adjacent to the fusion peptides
(blue). For simplicity, supercoiling of the coiled coil is not
depicted. The green loops represent the immunosuppressive and
the cysteine-rich regions. The free cysteine residues are shown in
yellow. The first two cysteine residues readily form a disulfide
bond (shown in orange), as judged by NTCB cleavage data and
the thermal stabilities of cysteine-to-alanine mutants (see text).
of the MMLV disulfide rearrangement required for
shedding of the SU subunit.
Conclusions
We propose that shedding of the SU subunit leaves behind
a folded, trimeric fusogenic complex (Fig. 6), similar to
the low-pH-induced structure of influenza HA [3]. In the
native state of influenza, the receptor-binding domains
inhibit formation of the extended coiled coil, thereby
serving as the basis of the "spring-loaded mechanism" [6]
for the HA conformational change. It remains to be seen
whether the residues corresponding to the coiled coil
identified here are in an alternative conformation in the
native SU-TM protein complex. In either case, because
the trimeric coiled-coil motif is found in analogous posi-
tions in the proposed fusion-competent states of the
influenza and Moloney murine leukemia viruses, it is
likely that coiled coils will also prove to be central to the
membrane-fusion mechanism of retroviruses.
Materials and methods
Production and purification of synthetic peptides
The Mo-36 peptide and a peptide six residues shorter at the
carboxyl terminus, Mo-30, were synthesized using Fmoc chem-
istry and purified using a method described previously [31].
These peptides contain non-native carboxy-terminal tyrosine
residues to facilitate concentration determination [32]. Mo-30
was predominantly unfolded and was not studied further.
Production and purification of recombinant peptides
A DNA fragment encoding Mo-92 was generated by PCR
from a plasmid containing the gene encoding the MMLV
envelope protein (kindly provided by D. Sanders and R.C.
Mulligan), using primers containing 5' NdeI and 3' BamHI
sites. The amplified fragment was subcloned into the pAED4
vector [33]. Plasmid pAED4 containing the sequence encoding
Mo-55 was prepared in a similar way, using a different 3' PCR
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primer. Both recombinant peptides included amino-terminal
methionine residues for expression. The sequences of the Mo-
92 and Mo-55 inserts, as well those of the mutant inserts, were
confirmed by dideoxy sequencing (USB). Mo-92 and Mo-55
were expressed in E. coli BL21(DE3) pLysS. Colonies were
picked directly from the plate, grown in LB until the
absorbance at 600 nm was 0.6, and then induced with 1 mM
IPTG. Cells were harvested by centrifugation 3 h later.
Mo-92 was purified by lysing cell pellets in glacial acetic acid
and centrifuging at 12 000 rpm for 20 min in a Sorvall RC-5B
equipped with an SS-34 rotor. The supernatant was collected
and diluted to 10 % acetic acid with water. The solution was
filtered and purified by reversed-phase high performance liquid
chromatography (HPLC) using a Vydac preparative C18 col-
umn. A linear water/acetonitrile gradient containing 0.1 %
TFA was used at a flow rate of 10 ml min 1. Mo-55 was puri-
fied by lysing cell pellets in a solution containing 100 mM
NaCl, 25 mM Tris (pH 8.0) and 0.1 % (v/v) -mercap-
toethanol. The lysate was centrifuged as described above. The
soluble fraction was applied under gravity to a 10 ml bed vol-
ume DEAE anion-exchange column. The column was washed
with a solution containing 20 ml 100 mM NaC1, 25 mM Tris
(pH 8.0) and 0.1 % (v/v) P-mercaptoethanol. Elution was per-
formed with 25 mM Tris (pH 8.0), 0.1 % (v/v) 13-mercap-
toethanol and a salt gradient from 100-500 mM NaCl. The
eluate fractions were analyzed on 18 % SDS-PAGE gels. Frac-
tions containing Mo-55 were pooled and brought to 10 %
acetic acid, filtered, and purified by reversed-phase HPLC.
Mutagenesis
DNAs encoding the cysteine-to-alanine mutant peptides were
prepared by oligonucleotide-directed mutagenesis of the con-
structs encoding the parent peptides [34]. Mutant peptides
were purified by the identical method used for purification of
the corresponding wild-type peptides. Oxidations for the
disulfide permutation experiments were performed by incuba-
ting 5 mg ml-1 mutant peptide in 6 M GuHCl, 0.5 mM
oxidized glutathione, 0.5 mM reduced glutathione and 20 mM
Tris (pH 8.8), for 24 h at room temperature. Samples were
brought to 10 % acetic acid, dialyzed at room temperature
against 5 % acetic acid for 48 h with two buffer changes, and
lyophilized. The absence of free thiols was confirmed by the
lack of reaction with Ellman's reagent in 6 M GuHCI [35]. In
each case, disulfide-bond formation 'was intramolecular as
judged by the absence of higher-order species on non-redu-
cing SDS-PAGE gels.
Protease digestion
A solution containing 5 mg ml-' Mo-92 and 0.8 mg ml-1
TPCK-treated trypsin (Sigma) in 25 mM Tris (pH 8.0), was
left overnight at room temperature. The digestion mixture was
then diluted 5-fold into 5 % acetic acid, and the trypsin-
resistant fragment was purified by reversed-phase HPLC. The
fragment had an observed molecular mass of 6 852 Da. The
expected mass for cleavage at ArglO04 is 6 856 Da. Mo-92
(5 mg ml-') and chymotrypsin (0.5 mg ml-') (Boehringer
Mannheim) were incubated at room temperature in 50 mM
KPO 4 (pH 7.0). Aliquots were diluted 1:10 in 5 % acetic acid
for mass spectrometry. Cleavage occurred after either Phe95 or
Tyr96, with observed masses of 5 851 and 6 007 Da, respec-
tively. Calculated masses are 5 843 and 6 007 Da. Longer
digestion times favored the shorter fragment. Cleavage of a
peptide containing residues from Met31 to Asp98 was carried
out with 5 mg ml-' peptide and 0.5 mg ml-' thermolysin in
25 mM Tris (pH 8.0), at 37 C for 6 h. A mass of 6 290 Da
was observed, as compared to the calculated mass of 6 289 Da
for a peptide from Val43 to Asp98.
CD spectroscopy
CD spectroscopy was performed using an Aviv 62DS
spectrometer equipped with a thermoelectric temperature con-
troller. Peptide concentrations were determined by tyrosine
absorbance at 275 nm using E = 1500 (Mo-30, -36, -55), or by
tryptophan and tyrosine absorbance at 280 nm using E = 6880
(Mo-92) [31]. The Mo-36, Mo-55, and Mo-92 peptide con-
centrations were 23 IbM, 10 IbM, and 10 p.M, respectively, in
50 mM NaPO 4, 150 mM NaCl (pH 7.0), for wavelength
scans. Scans were taken at 2 C, and signal was averaged for
5 sec. All thermal melting experiments were performed at
10 tpM in the same buffer. The CD signal was measured in
steps of 2 C, with a 1.5 min equilibration at each temperature.
The signal was averaged for 10 sec at each temperature. The
Tm for each peptide was determined from the peak in the first
derivative of the ellipticity against 1/T curve [36]. All Tm, val-
ues were determined from thermal unfolding experiments that
were > 90 % reversible. The number of helical residues in each
peptide was estimated from []222 by assuming that a value of
-33 000 deg cm2 dmol 1 corresponds to a helix content of
100 % [37]. The unfolded baseline of-4 000 deg cm2 dmol-1
was taken as 0 % helical.
Analytical ultracentrifugation
Equilibrium ultracentrifugation studies [38] were carried out
using a Beckman XL-A analytical ultracentrifuge, with an An-
60 Ti rotor at 20 C. Mo-92 in 1 ml 50 mM Tris (pH 8.8) was
dialyzed overnight against 500 ml 50 mM Tris (pH 8.8),
200 mM NaCI and 0.5 mM DTT. Mo-55 in 1 ml 100 mM
Tris (pH 8.8) was dialyzed overnight against 500 ml 50 mM
Tris (pH 8.8), 100 mM NaCI and 2 mM DTT. Fractions of
the sample were then diluted 1:2 and 1:8 with dialysate to gen-
erate protein solutions of approximately 100 RIM, 33 pIM and
11 pbM. Low concentrations of DTT were used as a precaution
against intermolecular disulfide bond formation; however,
subsequent studies showed reducing agent to be unnecessary.
Indeed, similar results were obtained for oxidized Mo-92.3,
which does not contain a free thiol, as for Mo-92 in presence
or absence of DTT. Mo-92 samples were spun in a six-sector
cell at rotor speeds of 15 000 and 17 000 rpm. Mo-55 was spun
at 20 000 rpm, 22 000 rpm and 24 000 rpm. Data for Mo-92
were collected for each speed and for each protein
concentration at 230 nm, 260 nm, 280 nm and 320 nm. Data
for Mo-55 were collected at 229 nm, 247 nm, 280 nm and
300 nm. Data were analyzed using the following equation:
M = [2RT/(1-)p 2 ] [d(ln(c))/dr2 ], with v as 0.732 cm 3 g1 for
Mo-92 and 0.730 cm 3 g 1 for Mo-55. In both cases, p was
1.01 g cm - 1.
NTCB cleavage
Mo-92 and Mo-55 were oxidized at 100 pLM by stirring
overnight in 20 mM Tris (pH 8.8). Samples were brought to
5 % acetic acid, dialyzed against 5 % acetic acid for 24 h, and
lyophilized. Oxidized Mo-92, Mo-55, or reduced cysteine-to-
alanine mutants were dissolved at 1 mM in 20 mM Tris
(pH 8.8). NTCB was added to 10 mM, followed by GuHC to
saturation. The sample was placed in the dark for 15 min at
37 C. NaOH (1N) was added until a pH - 9.5 was achieved,
and the cleavage reaction was allowed to proceed in the dark
for 8 h at 37 C [17]. An aliquot was diluted 1:10 in 70 %
CH 3CN, 0.1 % TFA for mass spectrometry. The observed
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masses for NTCB cleavage of Mo-92 were 5597 and 5 081 Da.
Expected masses for the amino- and carboxy-terminal frag-
ments of cleavage before the third cysteine in Mo-92 are 5 593
and 5 063 Da, respectively. A methionine sulfoxide in the car-
boxy-terminal fragment would lead to an expected mass of
5 079 Da. Cleavage of oxidized Mo-55 yielded an amino-ter-
minal fragment of 5 600 Da.
Mass spectrometry
Laser desorption mass spectrometry was performed on a
Voyager Elite BioSpectrometry Research Station (PerSeptive
Biosystems), using a matrix of 10 mg nml- t c-cyano-4-
hydroxycinnamic acid in 70 % CH 3 CN, 0.1 % TFA.
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